Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany.
Diabetes. 2011 May;60(5):1561-5. doi: 10.2337/db10-0474. Epub 2011 Mar 23.
Glucagon-like peptide (GLP)-1 lowers postprandial glycemia primarily through inhibition of gastric emptying. We addressed whether the GLP-1-induced deceleration of gastric emptying is subject to rapid tachyphylaxis and if so, how this would alter postprandial glucose control.
Nine healthy volunteers (25 ± 4 years old, BMI: 24.6 ± 4.7 kg/m(2)) were examined with intravenous infusion of GLP-1 (0.8 pmol · kg(-1) · min(-1)) or placebo over 8.5 h. Two liquid mixed meals were administered at a 4-h interval. Gastric emptying was determined, and blood samples were drawn frequently.
GLP-1 decelerated gastric emptying significantly more after the first meal compared with the second meal (P = 0.01). This was associated with reductions in pancreatic polypeptide levels (marker of vagal activation) after the first but not the second meal (P < 0.05). With GLP-1, glucose concentrations declined after the first meal but increased after the second meal (P < 0.05). The GLP-1-induced reductions in postprandial insulin and C-peptide levels were stronger during the first meal course (P < 0.05). Likewise, glucagon levels were lowered by GLP-1 after the first meal but increased after the second test meal (P < 0.05).
The GLP-1-induced delay in gastric emptying is subject to rapid tachyphylaxis at the level of vagal nervous activation. As a consequence, postprandial glucose control by GLP-1 is attenuated after its chronic administration.
胰高血糖素样肽-1(GLP-1)主要通过抑制胃排空来降低餐后血糖。我们研究了 GLP-1 诱导的胃排空减速是否会迅速产生快速耐受,如果是这样,这将如何改变餐后血糖控制。
9 名健康志愿者(25 ± 4 岁,BMI:24.6 ± 4.7 kg/m²)接受静脉输注 GLP-1(0.8 pmol·kg⁻¹·min⁻¹)或安慰剂,持续 8.5 小时。每 4 小时给予两种液体混合餐。确定胃排空情况,并频繁抽取血液样本。
GLP-1 使胃排空明显减速,在第一餐比第二餐更为明显(P = 0.01)。这与第一餐而不是第二餐的胰腺多肽水平降低(迷走神经激活的标志物)有关(P < 0.05)。给予 GLP-1 后,第一餐葡萄糖浓度下降,但第二餐增加(P < 0.05)。第一餐时,GLP-1 引起的餐后胰岛素和 C 肽水平降低更为明显(P < 0.05)。同样,第一餐时 GLP-1 降低了胰高血糖素水平,但第二餐时增加了(P < 0.05)。
GLP-1 诱导的胃排空延迟在迷走神经激活水平上迅速产生快速耐受。因此,GLP-1 的慢性给药后,其对餐后血糖的控制减弱。